Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Recursion Pharmaceuticals
(RXRX) Q3 2024
Earnings
RXRX
Aug 8
Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.45
-0.43
-0.4
-0.38
Details
Expected EPS
-0.384286
Actual EPS
-0.4
Surprise EPS
-0.02
Surprise Percent
-4.09%
Description
Recursion Pharmaceuticals (RXRX) has reported earnings of -0.4 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login